Literature DB >> 26629216

Computed tomography appearance of inflammatory myofibroblastic tumor in the abdomen: CT features and pathologic correlation.

Bo Liu1, Junlong Xu2, Jiaxin Wang3, Hongguang Fan4, Xuan Ang4, Wenming Liu5.   

Abstract

OBJECTIVE: To evaluate CT findings of abdominal inflammatory myofibroblastic tumor (IMT) and the relationship with morphological character.
MATERIALS AND METHODS: CT examinations and pathological findings of ten intra-abdominal IMTs were retrospectively analyzed. The histopathological characteristics of the IMTs were confirmed by two pathologists and two radiologists evaluated CT findings of the lesion, with emphasis on the imaging features compared with the corresponding histopathology.
RESULTS: The most common imaging characteristics were presence of heterogeneity, all tumors showed varying degrees of contrast enhancement. Two major different CT patterns were individualized. In type one, the tumor had a distinct boundary without a lobular appearance and displayed hypo-enhanced enhancement after administration of contrast in correlated with the mainly histopathologic findings of spindle cells myxoid and hypocellular fibrous (6/10; 60%). In type two, the lesions exhibited indistinct boundaries or complete capsule, ill-defined growth patterns or low intralesional attenuation with marked heterogeneous or circumferential enhancement, which correlated well with the presence of abundance of micromodule and inflammatory cell infiltration (4/10; 40%).
CONCLUSIONS: Two major different contrast enhancement CT patterns were individualized can help to determine the relationships with histopathologic findings, while cannot be reliably differentiated from other solid lesions based solely on the CT appearance, combined with diagnostic biopsy may facilitate to achieve a correct diagnosis and treatment.

Entities:  

Keywords:  Inflammatory myofibroblastic tumor; abdomen; computed tomography; histology

Year:  2015        PMID: 26629216      PMCID: PMC4659104     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  25 in total

1.  The rationale for nonsteroidal anti-inflammatory drug therapy for inflammatory myofibroblastic tumors: a Children's Oncology Group study.

Authors:  Harry Applebaum; Mark W Kieran; Timothy P Cripe; Cheryl M Coffin; Margaret H Collins; Arja Kaipainen; Andrea Laforme; Robert C Shamberger
Journal:  J Pediatr Surg       Date:  2005-06       Impact factor: 2.545

2.  Intestinal inflammatory pseudotumour with regional lymph node involvement: identification of a new bacterium as the aetiological agent.

Authors:  W Cheuk; P C Woo; K Y Yuen; P H Yu; J K Chan
Journal:  J Pathol       Date:  2000-11       Impact factor: 7.996

3.  Carboplatin plus paclitaxel in the successful treatment of advanced inflammatory myofibroblastic tumor.

Authors:  Naoki Kubo; Taishi Harada; Satoshi Anai; Kohei Otsubo; Yasuto Yoneshima; Kayo Ijichi; Takaomi Koga; Koichi Takayama; Yoichi Nakanishi
Journal:  Intern Med       Date:  2012-09-01       Impact factor: 1.271

4.  Inflammatory tumour of the retroperitoneum--a case report.

Authors:  V P Mali; H C Tan; D Loh; K Prabhakaran
Journal:  Ann Acad Med Singap       Date:  2005-11       Impact factor: 2.473

5.  Treatment of pseudotumors with nonsteroidal antiinflammatory drugs.

Authors:  W Su; A Ko; T O'Connell; H Applebaum
Journal:  J Pediatr Surg       Date:  2000-11       Impact factor: 2.545

6.  Radiological appearance of inflammatory myofibroblastic tumour.

Authors:  Darshana D Rasalkar; Winnie C W Chu; Ka-fai To; Frankie W T Cheng; C K Li
Journal:  Pediatr Blood Cancer       Date:  2010-07-01       Impact factor: 3.167

Review 7.  Inflammatory myofibroblastic tumor presenting as a pancreatic mass: a case report and review of the literature.

Authors:  Surakit Pungpapong; Xochi J Geiger; Massimo Raimondo
Journal:  JOP       Date:  2004-09-10

8.  Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

Authors:  Cheryl M Coffin; Jason L Hornick; Christopher D M Fletcher
Journal:  Am J Surg Pathol       Date:  2007-04       Impact factor: 6.394

Review 9.  Inflammatory myofibroblastic tumours: where are we now?

Authors:  B C Gleason; J L Hornick
Journal:  J Clin Pathol       Date:  2007-10-15       Impact factor: 3.411

10.  Inflammatory myoblastic tumor of the uterus and interleukin-6.

Authors:  Yoichi Azuno; Ken Yaga; Yasuko Suehiro; Shigemi Ariyama; Atsunori Oga
Journal:  Am J Obstet Gynecol       Date:  2003-09       Impact factor: 8.661

View more
  3 in total

1.  Imaging findings of inflammatory myofibroblastic tumor in breast: A case report.

Authors:  Xijin Mao; Hairong Liu; Jing Du; Ning Yu; Liang Chen; Lin Zhang
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.889

2.  Myofibroblastic infiltration of the bowel: A case report and literature review.

Authors:  M Tarazi; C L English; K Guest; D Balasubramaniam
Journal:  Int J Surg Case Rep       Date:  2018-09-06

3.  Imaging findings of inflammatory myofibroblastic tumor from the greater omentum: One case report.

Authors:  Wenjie Liang; Shengzhang Lin; Zhihua Chen
Journal:  Medicine (Baltimore)       Date:  2017-10       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.